Summary
Sustanon by Hilma Biocare, batch number 063052, underwent independent testing to verify its quality and accuracy of label claims. The sample, containing a blend of testosterone esters, was submitted by hilmabiocare.com and analyzed by Janoshik Analytical. The lab measured a total concentration of 240.99 mg/ml, with specific esters present at varying levels.
The testing process began on 24 January 2024, with the sample received on 8 February 2024, and analysis completed on 12 February 2024. These findings suggest accurate formulation but emphasize the importance of interpreting manufacturer-funded testing with caution, as manufacturers may submit select batches. Cross-verification through third-party testing remains critical to ensure transparency and consumer safety.
Detailed Report
Product Overview
- Manufacturer: Hilma Biocare
- Product Name: Sustanon
- Active Ingredient: Testosterone esters (Propionate, Phenylpropionate, Isocaproate, Decanoate)
- Batch Number: Sustanon – 063052
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #38451
- Testing Ordered: 24 January 2024
- Sample Received: 8 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Hilma Biocare
- Analysis Paid For By: Hilma Biocare
Testing Results
- Specification: Not specified (Sustanon blend)
- Measured Concentration: 240.99 mg/ml
- 28.36 mg/ml Testosterone Propionate
- 58.95 mg/ml Testosterone Phenylpropionate
- 56.90 mg/ml Testosterone Isocaproate
- 96.78 mg/ml Testosterone Decanoate
Verification Details
- Verification URL: https://janoshik.com/tests/38451_JILKA9XJGETI
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Sustanon by Hilma Biocare contains a total testosterone ester concentration close to expectations. However, the sample was both submitted and funded by the manufacturer, which may introduce potential biases. Selective batch submissions could affect the reliability of results across the product line. Independent, third-party testing remains a key aspect of ensuring product consistency and transparency for consumers.
Conclusion
The lab results verify the potency of Sustanon by Hilma Biocare, with a measured concentration of 240.99 mg/ml. Although the findings are favorable, further testing from independent sources is recommended to guarantee consistent dosing across all batches. This report serves to promote transparency and harm reduction through detailed analysis.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
